Facebook page "JSP Pharma - JP สุภาพโอสถ70ปี" impersonates "JSP Pharmaceutical Manufacturing (Thailand) Plc." : Unlicensed securities and derivatives business (Disclosure Date : 05/03/2025)
Facebook page AMATA - Capital Gain : Unlicensed securities and derivatives business (Disclosure Date : 16/05/2023)
Facebook page Capital Gain : Unlicensed securities and derivatives business (Disclosure Date : 15/04/2022)
Facebook page AMATA - Capital Gain : Unlicensed securities and derivatives business (Disclosure Date : 16/05/2023)
Facebook page Capital Gain : Unlicensed securities and derivatives business (Disclosure Date : 15/04/2022)
decelerating rate due to slowdown in external sector and manufacturing production at home. Meanwhile, private consumption which continued to expand was derived mainly from increased expenditures on automobiles
Platform of Choice” in order to maintain existing clients with good track records while also broadening opportunities to acquire new patrons via digital channels. KASIKORNBANK has established its business
bring about multiple risks that are more severe, more complex, and with a more Given the hyperconnectedness of businesses within the ecosystem, businesses may gain benefits but may also be exposed to
, plants and equipment of THB 135 million since all the https://market.sec.or.th/public/idisc/Download?FILEID=dat/news/201908/19075817.pdf 10 acquire shares equivalent to 37.5 percent, and has expended Baht
135 million since all the https://market.sec.or.th/public/idisc/Download?FILEID=dat/news/201908/19075817.pdf 10 acquire shares equivalent to 37.5 percent, and has expended Baht 324,999,779.28 in